<DOC>
	<DOCNO>NCT01372111</DOCNO>
	<brief_summary>Concurrent chemotherapy radiation therapy ( chemoRT ) become standard care treatment many patient advanced head neck squamous cell carcinoma ( HNSCC ) , though many clinical question remain . Prior experience reveal locoregional control ( LRC ) , disease free survival ( DFS ) overall survival ( OS ) 3 year exceed 80 % treatment use hyperfractionated intensity modulate radiation therapy ( IMRT ) concurrent weekly cisplatin chemotherapy patient locally advanced HNSCC . This multi-institutional phase II ZCC00204 trial result acceptable quality life ( QOL ) toxicity profile . The current trial attempt maintain high LRC , minimize acute chronic toxicity , maximize QOL .</brief_summary>
	<brief_title>Chemoradiotherapy With Elective Low Dose Nodal Radiation Locally Advanced Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Biopsy proven squamous cell carcinoma oral cavity , oropharynx , hypopharynx , larynx No surgical resection primary site neck dissection ( excisional biopsy lymph node permit ) Human Papilloma Virus ( HPV ) test tumor perform ; HPV p16 immunohistochemistry Stage III IVa disease ( T12N13M0 , T34N03M0 ) exclude T12N1 oral cavity tonsil primary N2C bilateral N3 disease . Patients T2N0 cancer base tongue hypopharynx eligible ECOG performance status 01 Age &gt; 18 year No current pregnancy No invasive malignancy within last 2 year Patients basal cell squamous cell skin cancer carcinoma situ site eligible . No prior radiotherapy head neck region No prior cisplatin chemotherapy No symptomatic coronary disease myocardial infarction within last 6 month Laboratory evaluation : ANC &gt; 2,000/mm3 , platelet &gt; 100,000/mm3 , creatinine &lt; 1.5 mg/dl , creatinine clearance &gt; 50 ml/min , bilirubin &lt; 1.5 mg/dl , AST ALT &lt; 2X upper normal limit Studyspecific consent sign prior entry Second primary malignancy clinically detectable Inability unwillingness comply chemoRT Prior radiotherapy , chemotherapy , investigational treatment squamous cell carcinoma head neck . Metastatic disease ( M1 ) Pregnant breastfeed woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Stg III IVa Squamous Cell Carcinoma .</keyword>
	<keyword>Advanced</keyword>
</DOC>